borderline significanceP = 0.07
ABCG2 34A allele showed a reduced risk for severity of LDHIV with borderline significance ( P = 0.07, OR = 0.55).
ABCG2 34A allele showed a reduced risk for severity of LDHIV with borderline significance ( P = 0.07, OR = 0.55).
In patients without HIVLD, the ABCG2 34GA genotype was associated with impaired triglyceride levels with marginal significance and showed an increased risk for the development of dyslipidemia ( P = 0.07, OR = 2.76).